Arcellx (ACLX)

• Market cap: $5.21B
• 1 day: -0.1%
• 5 days: 3.02%
• 1 month: 4.53%
• 3 months: 24.3%
• 6 months: 51.5%
• Year to date: 14.46%
• 1 year: -10.29%
• 5 years: 436.55%
• 10 years: 436.55%
• Sector: Healthcare
• Industry: Biotechnology

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 163